Why the study?
Does enalaprilat increase renal cortical and medullary blood flow via bradykinin potentiation in sodium-depleted dogs after AT1 receptor blockade?
Does enalaprilat increase renal cortical and medullary blood flow via bradykinin potentiation in sodium-depleted dogs after AT1 receptor blockade?
ACE inhibitor-induced renal vasodilation in sodium-depleted dogs is substantially mediated by bradykinin potentiation, with a greater effect on medullary compared to cortical blood flow.
Answers are grounded in this paper and cite their sources.
Highlights bradykinin potentiation in ACEI renal vasodilation in dogs; leaves open translation to human cardiorenal therapies.
The relative contributions of ANG II and bradykinin (BK) to the renal regional blood flow responses during angiotensin-converting enzyme (ACE) inhibition remain unclear. This study was performed to evaluate renal cortical (CBF) and medullary blood flow (MBF) responses to intrarterial administration of enalaprilat (33 microg. kg(-1). min (-1)) after blockade of the ANG II AT(1 )receptors with candesartan (100 microg) in 7 dogs fed a low-salt diet (0.01%) for 5 days. Laser-Doppler flowmetry was used to measure relative changes in CBF and MBF. Candesartan alone increased CBF (+20 +/- 2%) and MBF (+22 +/- 7%). Enalaprilat infusion after candesartan administration resulted in further increases in both CBF (+21 +/- 5%) and MBF (+41 +/- 8%). However, the relative changes in MBF were significantly greater (P < 0.01) than those in CBF. Administration of the BK B(2) receptor blocker icatibant (300 microg) after enalaprilat returned CBF and MBF to values seen with candesartan alone. These data support a substantive role for BK potentiation during ACE inhibitor-induced renal vasodilation in dogs maintained on a low-sodium diet, with a relatively greater effect on MBF compared to CBF.
No takes yet. Share an insight, caveat, or question.
Omoro et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: